- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00978887
Retorna Facial Cream in the Treatment of Facial Wrinkles
May 17, 2010 updated by: Catalysis SL
Efficacy of Retorna Facial Cream Usage in the Treatment of Facial Wrinkles
The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles.
The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks.
The estimated number of women to be recruited and randomized for the study is 148.
Occurrence of adverse effects will also be evaluated.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
148
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Havana
-
Havana City, Havana, Cuba, 10400
- "Commander Manuel Fajardo Rivero" Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Facial wrinkles
- Signed informed consent
- Given verbal agreement on solar exposure prevention within hours of intense solar radiation (10 am - 4 pm) by the usage of physical protection methods such as umbrellas, caps and hats.
Exclusion Criteria:
- Pregnancy
- Breast-feeding
- Use of steroids within 6 months.
- Patients under other experimental treatment
- Decompensated concomitant diseases
- Malignant neoplastic conditions.
- Alcoholism
- Handicap and/or psychiatric condition preventing treatment accomplishment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: A
Retorna (facial cream)
|
Dosage commensurate with surface to be treated, Retorna facial cream (Topical use), twice a day, for 4 weeks.
|
PLACEBO_COMPARATOR: B
Placebo (facial cream)
|
Dosage commensurate with surface to be treated, Placebo facial cream (Topical use), twice a day, for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total correction or improvement of facial wrinkles at the end of treatment (4 weeks)
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Presence of adverse effects within the 4 week treatment period
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jose Dominguez Gómez, MD, "Commander Manuel Fajardo Rivero" Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (ACTUAL)
May 1, 2010
Study Completion (ACTUAL)
May 1, 2010
Study Registration Dates
First Submitted
September 16, 2009
First Submitted That Met QC Criteria
September 16, 2009
First Posted (ESTIMATE)
September 17, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
May 18, 2010
Last Update Submitted That Met QC Criteria
May 17, 2010
Last Verified
May 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAT-0906-CU
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Wrinkles
-
The Plastic Surgery FoundationCompletedFacial Photo Damage | Periocular Fine Wrinkles | Perioral Fine WrinklesUnited States
-
DeYi Aesthetic Medical ClinicNot yet recruiting
-
Genzyme, a Sanofi CompanyCompleted
-
PollogenUnknownFacial WrinklesUnited States
-
ConturaCompletedFacial WrinklesUnited States
-
Genzyme, a Sanofi CompanyInamed AestheticsCompleted
-
YMD Eye and FaceCompletedFacial WrinklesUnited States
-
Merz North America, Inc.CompletedFacial WrinklesUnited States
-
Merz North America, Inc.CompletedFacial WrinklesUnited States
-
Phytotox SAWithdrawn